Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
Crossref DOI link: https://doi.org/10.1007/s11523-020-00772-4
Published Online: 2020-11-12
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Niederwieser, Dietger http://orcid.org/0000-0002-4737-1103
Hamm, Caroline
Cobb, Patrick
Mo, Mindy
Forsyth, Cecily
Tucci, Alessandra
Hanes, Vladimir
Delwail, Vincent
Hajek, Roman
Chien, David
Text and Data Mining valid from 2020-11-12
Version of Record valid from 2020-11-12
Article History
First Online: 12 November 2020